BD Elects Jeffrey Henderson to Board of Directors
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: PR Newswire
FRANKLIN LAKES, N.J., Aug. 16, 2018 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Jeffrey W. Henderson has been elected to the company's board of directors. Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving as an advisory director to Berkshire Partners LLC. Prior to these roles, he served for nearly 10 years as chief financial officer of Cardinal Health, a $137 billion global health care services and products company, and also oversaw the company's China and Canada operations. Prior to Cardinal Health, Henderson spent seven years at Eli Lilly & Co. where he was vice president and corporate controller, as well as president and general manager of its Canada operations. He also spent 10 years at General Motors Corp. holding a variety of leadership rol
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- 2024 Report | European Biopsy Devices Market to Reach US$ 1,074.0 Million by 2032: Enhanced Focus on Early Disease Detection Fuels Growth [Yahoo! Finance]Yahoo! Finance
- Sepsis Diagnostics Market is Expected to Reach $890 million | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- AvaSure Appoints Technology Veteran Paula Cobb as Vice President of Marketing [Yahoo! Finance]Yahoo! Finance
- Injectable Drug Delivery Market To Reach USD 1,714.8 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- BDX or MMSI: Which Is the Better Value Stock Right Now? [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 2/1/24 - Beat
BDX
Sec Filings
- 4/5/24 - Form 4
- 3/15/24 - Form 4
- 3/14/24 - Form 144
- BDX's page on the SEC website